PL2546255T3 - Związek benzazepiny - Google Patents
Związek benzazepinyInfo
- Publication number
- PL2546255T3 PL2546255T3 PL11753475T PL11753475T PL2546255T3 PL 2546255 T3 PL2546255 T3 PL 2546255T3 PL 11753475 T PL11753475 T PL 11753475T PL 11753475 T PL11753475 T PL 11753475T PL 2546255 T3 PL2546255 T3 PL 2546255T3
- Authority
- PL
- Poland
- Prior art keywords
- benzazepine compound
- benzazepine
- compound
- Prior art date
Links
- -1 Benzazepine compound Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31313310P | 2010-03-12 | 2010-03-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2546255T3 true PL2546255T3 (pl) | 2017-02-28 |
Family
ID=44563615
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11753475T PL2546255T3 (pl) | 2010-03-12 | 2011-03-11 | Związek benzazepiny |
Country Status (25)
| Country | Link |
|---|---|
| US (4) | US20110269744A1 (pl) |
| EP (1) | EP2546255B1 (pl) |
| JP (1) | JP5747910B2 (pl) |
| KR (1) | KR101769642B1 (pl) |
| CN (1) | CN102869665B (pl) |
| AU (1) | AU2011225108C1 (pl) |
| BR (1) | BR112012022915B1 (pl) |
| CA (1) | CA2792918C (pl) |
| CY (1) | CY1118268T1 (pl) |
| DK (1) | DK2546255T3 (pl) |
| EA (1) | EA023039B1 (pl) |
| ES (1) | ES2605466T3 (pl) |
| HR (1) | HRP20161529T1 (pl) |
| HU (1) | HUE031082T2 (pl) |
| IL (1) | IL221737A (pl) |
| LT (1) | LT2546255T (pl) |
| MX (1) | MX338130B (pl) |
| PH (1) | PH12012501735A1 (pl) |
| PL (1) | PL2546255T3 (pl) |
| PT (1) | PT2546255T (pl) |
| RS (1) | RS55362B1 (pl) |
| SI (1) | SI2546255T1 (pl) |
| TW (1) | TWI495640B (pl) |
| UA (1) | UA110479C2 (pl) |
| WO (1) | WO2011111817A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015066344A1 (en) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
| GB2520266A (en) * | 2013-11-13 | 2015-05-20 | Ibm | Cursor-Based Character input interface |
| EA037299B1 (ru) * | 2014-09-17 | 2021-03-05 | Селджен Кар Ллс | Ингибиторы mk2 и их применения |
| US10452679B2 (en) * | 2016-09-30 | 2019-10-22 | Google Llc | Systems and methods for context-sensitive data annotation and annotation visualization |
| US20210052600A1 (en) * | 2017-12-27 | 2021-02-25 | Takeda Pharmaceutical Company Limited | Therapeutic agents for stress urinary incontinence and incotinence of feces |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2002074746A1 (ja) | 2001-03-16 | 2004-07-08 | 山之内製薬株式会社 | ベンゾアゼピン誘導体 |
| US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
| US7704993B2 (en) * | 2003-06-17 | 2010-04-27 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
| WO2005042491A1 (en) | 2003-10-22 | 2005-05-12 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
| WO2005042490A1 (en) | 2003-10-22 | 2005-05-12 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
| EA011011B1 (ru) * | 2004-02-25 | 2008-12-30 | Эли Лилли Энд Компани | 6-ЗАМЕЩЁННЫЕ 2,3,4,5-ТЕТРАГИДРО-1H-БЕНЗО[d]АЗЕПИНЫ В КАЧЕСТВЕ АГОНИСТОВ РЕЦЕПТОРОВ 5-HT |
| GB0412314D0 (en) | 2004-06-02 | 2004-07-07 | Glaxo Group Ltd | Compounds |
| TW201031661A (en) | 2009-02-17 | 2010-09-01 | Targacept Inc | Fused benzazepines as neuronal nicotinic acetylcholine receptor ligands |
-
2011
- 2011-03-09 US US13/044,080 patent/US20110269744A1/en not_active Abandoned
- 2011-03-11 PT PT117534750T patent/PT2546255T/pt unknown
- 2011-03-11 HR HRP20161529TT patent/HRP20161529T1/hr unknown
- 2011-03-11 HU HUE11753475A patent/HUE031082T2/en unknown
- 2011-03-11 PL PL11753475T patent/PL2546255T3/pl unknown
- 2011-03-11 PH PH1/2012/501735A patent/PH12012501735A1/en unknown
- 2011-03-11 DK DK11753475.0T patent/DK2546255T3/en active
- 2011-03-11 WO PCT/JP2011/055759 patent/WO2011111817A1/ja not_active Ceased
- 2011-03-11 BR BR112012022915-0A patent/BR112012022915B1/pt not_active IP Right Cessation
- 2011-03-11 EP EP11753475.0A patent/EP2546255B1/en active Active
- 2011-03-11 RS RS20161038A patent/RS55362B1/sr unknown
- 2011-03-11 CN CN201180013703.2A patent/CN102869665B/zh not_active Expired - Fee Related
- 2011-03-11 CA CA2792918A patent/CA2792918C/en active Active
- 2011-03-11 US US13/583,410 patent/US20130012496A1/en not_active Abandoned
- 2011-03-11 TW TW100108310A patent/TWI495640B/zh not_active IP Right Cessation
- 2011-03-11 AU AU2011225108A patent/AU2011225108C1/en not_active Ceased
- 2011-03-11 EA EA201290905A patent/EA023039B1/ru not_active IP Right Cessation
- 2011-03-11 LT LTEP11753475.0T patent/LT2546255T/lt unknown
- 2011-03-11 ES ES11753475.0T patent/ES2605466T3/es active Active
- 2011-03-11 JP JP2012504533A patent/JP5747910B2/ja not_active Expired - Fee Related
- 2011-03-11 MX MX2012010570A patent/MX338130B/es active IP Right Grant
- 2011-03-11 KR KR1020127026576A patent/KR101769642B1/ko not_active Expired - Fee Related
- 2011-03-11 SI SI201131007A patent/SI2546255T1/sl unknown
- 2011-11-03 UA UAA201211777A patent/UA110479C2/uk unknown
-
2012
- 2012-09-02 IL IL221737A patent/IL221737A/en not_active IP Right Cessation
- 2012-09-13 US US13/613,948 patent/US9108977B2/en active Active
-
2015
- 2015-07-13 US US14/797,277 patent/US9598434B2/en not_active Expired - Fee Related
-
2016
- 2016-11-29 CY CY20161101235T patent/CY1118268T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL223783A0 (en) | Pro-neurogenic compounds | |
| GB201008134D0 (en) | Compounds | |
| GB201015949D0 (en) | Compounds | |
| PL2619208T3 (pl) | Związki imidazotriazynonu | |
| HUE040101T2 (hu) | Szubsztituált piridinon-piridinil-származékok | |
| GB201007347D0 (en) | Compounds | |
| EP2649050A4 (en) | LINKS | |
| GB201002563D0 (en) | Compounds | |
| IL219132A0 (en) | Benzazepine compound | |
| GB201008209D0 (en) | Compounds | |
| GB201001688D0 (en) | Compounds | |
| LT2546255T (lt) | Benzazepino junginys | |
| GB201017315D0 (en) | Compound | |
| GB201002911D0 (en) | Compound | |
| GB201007789D0 (en) | Novel Compound | |
| GB201002216D0 (en) | Compounds | |
| GB201001796D0 (en) | Compounds | |
| GB201015537D0 (en) | Compounds | |
| GB201008210D0 (en) | Compounds | |
| GB201007209D0 (en) | Compound | |
| GB201021494D0 (en) | Compounds | |
| GB201013507D0 (en) | Compounds | |
| GB201005980D0 (en) | Compound | |
| GB201015798D0 (en) | Compound | |
| GB201021228D0 (en) | Compound |